The clinical spectrum of prostate cancer ranges from curable, local disease to widely metastatic, lethal cancer.
Two new prostate cancer genome studies provide the first glimpse at both ends of this spectrum.
Written by:
Hieronymus H, Sawyers CL. Are you the author?
Reference: Nat Genet. 2012 May 29;44(6):613-4.
doi: 10.1038/ng.2301
PubMed Abstract
PMID: 22641202
UroToday.com Investigative Urology Section
